Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,305 | 50 | 92.9% |
| Education | $99.99 | 1 | 7.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $454.73 | 8 | $0 (2024) |
| Novo Nordisk Inc | $167.83 | 5 | $0 (2024) |
| Amgen Inc. | $165.00 | 9 | $0 (2020) |
| Astellas Pharma US Inc | $117.99 | 2 | $0 (2018) |
| Kowa Pharmaceuticals America, Inc. | $110.00 | 5 | $0 (2022) |
| Allergan Inc. | $99.24 | 6 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $63.61 | 4 | $0 (2017) |
| GlaxoSmithKline, LLC. | $48.08 | 3 | $0 (2020) |
| Galderma Laboratories, L.P. | $26.31 | 1 | $0 (2018) |
| Shire North American Group Inc | $21.35 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $278.91 | 4 | AstraZeneca Pharmaceuticals LP ($244.14) |
| 2022 | $36.68 | 2 | Kowa Pharmaceuticals America, Inc. ($21.39) |
| 2021 | $117.77 | 2 | Novo Nordisk Inc ($117.77) |
| 2020 | $115.53 | 7 | AstraZeneca Pharmaceuticals LP ($48.48) |
| 2019 | $223.61 | 6 | AstraZeneca Pharmaceuticals LP ($122.55) |
| 2018 | $366.35 | 15 | Astellas Pharma US Inc ($99.99) |
| 2017 | $266.23 | 15 | SANOFI-AVENTIS U.S. LLC ($63.61) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Respiratory | ||||||
| 08/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Obesity | ||||||
| 04/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $122.30 | General |
| Category: Respiratory | ||||||
| 06/30/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $21.39 | General |
| Category: Cardiovascular | ||||||
| 06/02/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Diabetes | ||||||
| 12/09/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Diabetes | ||||||
| 07/01/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $99.59 | General |
| Category: Obesity | ||||||
| 09/30/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/17/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: RESPIRATORY | ||||||
| 08/06/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/29/2020 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Inflammation | ||||||
| 05/28/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/11/2020 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $21.91 | General |
| Category: Cardiovascular | ||||||
| 01/15/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Neuroscience | ||||||
| 11/07/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $122.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/16/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Neuroscience | ||||||
| 07/24/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Cardiology | ||||||
| 07/17/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $24.60 | General |
| Category: Cardiovascular | ||||||
| 03/29/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Neuroscience | ||||||
| 03/14/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Hypertriglyceridemia | ||||||
| 09/28/2018 | Shire North American Group Inc | GATTEX (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/26/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Neuroscience | ||||||
| 09/20/2018 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/30/2018 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,377 | 1,774 | $149,000 | $114,701 |
| 2022 | 15 | 1,283 | 1,720 | $133,130 | $101,245 |
| 2021 | 14 | 1,240 | 1,784 | $137,500 | $105,910 |
| 2020 | 14 | 1,110 | 1,534 | $100,610 | $78,486 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 199 | 214 | $42,800 | $30,149 | 70.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 185 | 185 | $26,825 | $24,747 | 92.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 167 | 208 | $31,095 | $20,980 | 67.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 50 | 50 | $15,210 | $14,101 | 92.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 113 | 116 | $9,280 | $8,334 | 89.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 203 | 501 | $4,505 | $3,851 | 85.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 113 | 116 | $4,640 | $3,661 | 78.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 45 | $4,740 | $3,174 | 67.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 187 | 205 | $5,125 | $2,390 | 46.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 50 | 50 | $2,000 | $1,578 | 78.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 24 | $1,560 | $1,095 | 70.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 25 | 28 | $900.00 | $530.88 | 59.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 22 | 32 | $320.00 | $109.12 | 34.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 190 | 233 | $46,600 | $32,922 | 70.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 181 | 181 | $26,245 | $24,670 | 94.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 148 | 173 | $25,095 | $17,342 | 69.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 111 | 112 | $8,910 | $7,660 | 86.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 113 | 114 | $3,420 | $3,355 | 98.1% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 12 | 12 | $3,150 | $2,987 | 94.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 190 | 204 | $5,100 | $2,380 | 46.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $2,640 | $2,070 | 78.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 29 | $3,050 | $1,989 | 65.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 12 | 12 | $1,800 | $1,575 | 87.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 203 | 502 | $2,510 | $1,489 | 59.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 37 | 43 | $1,300 | $803.20 | 61.8% |
About Dr. Evan Shapiro, MD
Dr. Evan Shapiro, MD is a Internal Medicine healthcare provider based in Palm Beach Gardens, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2008. The National Provider Identifier (NPI) number assigned to this provider is 1528230653.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Evan Shapiro, MD has received a total of $1,405 in payments from pharmaceutical and medical device companies, with $278.91 received in 2024. These payments were reported across 51 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,305).
As a Medicare-enrolled provider, Shapiro has provided services to 5,010 Medicare beneficiaries, totaling 6,812 services with total Medicare billing of $400,341. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Palm Beach Gardens, FL
- Active Since 03/28/2008
- Last Updated 07/29/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1528230653
Products in Payments
- AIRSUPRA (Drug) $244.14
- FARXIGA (Drug) $171.03
- Wegovy (Drug) $115.67
- Livalo (Drug) $110.00
- BYSTOLIC (Drug) $84.56
- Aimovig (Biological) $71.54
- PRALUENT (Drug) $63.61
- Repatha (Biological) $58.89
- XIFAXAN (Drug) $41.48
- SYMBICORT (Drug) $39.56
- SHINGRIX (Biological) $36.61
- Ozempic (Drug) $33.98
- GATTEX (Drug) $21.35
- Vascepa (Drug) $20.60
- Prolia (Biological) $19.08
- VALCHLOR MECHLORETHAMINE (Drug) $19.07
- RYBELSUS (Drug) $18.18
- Myrbetriq (Drug) $18.00
- BELSOMRA (Drug) $17.97
- ENSTILAR (Drug) $16.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Palm Beach Gardens
Dr. Ravi Pandey, Md, MD
Internal Medicine — Payments: $17,395
Dr. Rupesh Dharia, M.d, M.D
Internal Medicine — Payments: $15,087
Amir Fahmy, Md, MD
Internal Medicine — Payments: $12,315
Romel Arjona, M.d, M.D
Internal Medicine — Payments: $9,757
Alissa O'brien, M.d, M.D
Internal Medicine — Payments: $7,028
Javier Canasi, Md, MD
Internal Medicine — Payments: $4,890